Yongfa Zhang
7PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 12, 2023
Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma.Bingran Yu, Ning Zhang, Yun Feng
|Jun 05, 2023
ZNF655 promotes the progression of hepatocellular carcinoma through PSMB8.Shasha Fan, Yu Liu, Zhenhai Lin
|Jun 18, 2021
Prognostic Value of the Preoperative Lymphocyte-C-Reactive Protein Ratio in Hepatocellular Carcinoma Patients Treated with Curative Intent: A Large-Scale Multicentre Study.Yong-Fa Zhang, Liang-He Lu, Chong Zhong
|Apr 28, 2021
Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.Yong-Fa Zhang, Ming Shi, Liang-He Lu
|Apr 08, 2021
Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma.Yong-Fa Zhang, Yi-Xiu Wang, Ning- Zhang
Pageof 2
